User banner image
User avatar
  • admin

Posts

Pluvicto™ demonstrated consistent efficacy across key patient subgroups in metastatic hormone-sensitive prostate cancer

Improved radiographic progression-free survival (rPFS) regardless of disease volume or metastatic presentation achieved with Pluvicto plus standard of care (ARPI + ADT) in PSMAddition Consistent...

AI: Digital to Physical | BEYOND Expo 2026 Leads Transformative Global Direction of Tech

MACAO, May 31, 2026 /PRNewswire/ — The BEYOND Expo 2026 has shown what the future looks like as it delivers on its mission of ‘Empowering Asia,...

Golden Goblet Competition Lineup Announced: Spotlight on the 2026 Contenders

SHANGHAI, May 31, 2026 /PRNewswire/ — The 28th Shanghai International Film Festival (SIFF) has officially unveiled the competition selections for the 2026 Golden Goblet Awards....

Dizal Presents Positive NSCLC Data for Fourth-Generation EGFR TKI DZD6008 and Golidocitinib in Combination with Anti-PD-1 at ASCO 2026

Oral presentation of DZD6008 demonstrated strong and durable anti-tumor activity, excellent BBB-penetrant properties, and a favorable safety profile in patients relapsed from third-generation EGFR TKI...

Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC Published in The Lancet

CHENGDU, China, May 31, 2026 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the “Company”, 6990.HK) announced today that the results of the Phase III clinical study...

Global Times: Chinese artisan weaves Zhuang brocade into World Cup

Global Times: Guangxi’s Zhuang brocade becomes official FIFA World Cup merchandise, showcasing China’s cultural heritage. Beijing, CHINA, May 30, 2026 (GLOBE NEWSWIRE) — Incorporating elements...

Global Times: At 80, award winning illustrator Cai Gao still draws inspiration from childhood

Global Times: Cai Gao, China’s first Hans Christian Andersen Award winner, blends tradition and childhood wonder across 50 years of art. Beijing, CHINA, May 30,...

Global Times: China demonstrates remarkable ability to set a long-term vision and actually execute it

Global Times: Expert Chandran Nair sees China’s 15th Five-Year Plan as a global stability anchor, prioritising rural growth and sustainability. Beijing, CHINA, May 30, 2026...

Orion Pharma announces first results from Phase 1/2 TEADES trial with TEAD inhibitor ODM-212 in patients with advanced solid tumours

ORION CORPORATION PRESS RELEASE 30 MAY 2026 at 21:30 EEST         Orion Pharma announces first results from Phase 1/2 TEADES trial with TEAD inhibitor ODM-212 in patients...

Eikon Therapeutics Presents Data on Clinical-Stage Programs at the 2026 Annual Meeting of the American Society of Clinical Oncology

TeLuRide-005, a Phase 2 trial of EIK1001 in first-line patients with stage 4 NSCLC completed enrollment of both non-squamous and squamous cohorts and reports updated...